Diet, exercise, and your treatment plan can help you manage your type 2 diabetes over time. If you've stopped making progress or your A1c is moving further away from your goal - even if you're currently taking an injectable [insulin] treatment - it could be that your diabetes is changing. If so, your treatment may need to change too, and your doctor may recommend SOLIQUA 100/33, a 2-in-1 medicine proven to help lower your A1c along with diet and exercise.

What is SOLIQUA 100/33

SOLIQUA 100/33 is an injectable treatment that goes beyond what insulins can do alone when used with diet and exercise. It combines two medicines that work together in a single, once-daily dose to deliver proven A1c reduction.

2 medicines work together in a single pen

  • Lantus® (insulin glargine injection) 100 Units/mL — a long-acting insulin
  • Adlyxin® (lixisenatide injection) — a non-insulin glucagon-like peptide-1 receptor agonist (GLP-1 RA)

SOLIQUA 100/33 works 5 ways to deliver proven A1c reduction

See how SOLIQUA 100/33, a type 2 diabetes treatment for adults, works 5 ways.

Pay as little as $9* with the CO-PAY Card

Eligible commercially insured patients save on SOLIQUA 100/33: Pay as little as $9* for a 30-day supply.
*Maximum savings of $365 per pack. Terms & conditions apply.